Marrow Infiltrating Lymphocytes: Their Role in Adoptive Immunotherapy

Area of Science:

• Immunology
• Oncology
• Cell Therapy

Background:

• Immunotherapy has become a cornerstone of cancer treatment.
• Adoptive T-cell therapy is a rapidly evolving field.
• Marrow-infiltrating lymphocytes (MILs) are T cells residing in the bone marrow (BM).

Purpose of the Study:

• To explore MILs as a novel source for adoptive T-cell therapy.
• To investigate the potential of MILs in treating hematologic malignancies and solid tumors.
• To evaluate MILs for gene modification strategies like CAR T-cell therapy.

Main Methods:

• Obtaining and expanding MILs from the BM.
• Utilizing MILs in ongoing clinical trials for myeloma and relapsed disease post-transplant.
• Conducting preclinical evaluations of MILs for solid and pediatric cancers.

Main Results:

• MILs are antigen-experienced T cells with enhanced endogenous tumor specificity.
• MILs can be readily obtained from BM and expanded.
• MILs are currently used in clinical trials for myeloma and relapsed disease.

Conclusions:

• MILs represent a distinctive T-cell population shaped by the BM microenvironment.
• MILs show potential as a future immunotherapy for hematologic malignancies.
• MILs may be an ideal cell source for gene-modified cell therapies, including CAR T-cell therapy.